ApolloMed Completes Funding; NASDAQ-Listing Imminent
In mid-October, Apollo Medical Holdings (OTC: AMEH) received a $10 million strategic equity investment from Network Medical Management, one of the largest healthcare management services organizations in California. This is a significant milestone for AMEH and sets the stage for its uplisting to NASDAQ.
"Network Medical Management and ApolloMed share a common mission to meet the triple aim of improving the patient's experience of care, improving the health of populations and reducing the per capita costs of healthcare," stated Kenneth Sim, M.D., Co-Chairman of Network Medical Management. "We are excited to join forces with the ApolloMed team as we improve healthcare delivery for our own patients as well as our client's patients."
AMEH is a leading population management and physician healthcare delivery company that provides accountable healthcare through medical management and care coordination for over 1,000 providers and 40,000 patients; including many senior patients. In addition, AMEH doctors provide care for over 100,000 patients in hospitals, facilities, and clinics.
Operating on a March 31 fiscal year, AMEH already reported first quarter results for fiscal 2016. In the quarter ended June 30, the Company reported net revenue up 149% year-over-year to $10.2 million. Despite this triple-digit growth, the Company’s shares remain significantly undervalued, creating a great opportunity for investors familiar with the story to accumulate shares ahead of its uplisting to NASDAQ.
RedChip analysts have a target price of $29 per share for AMEH, a potential gain of more than 300% from the microcap stock’s recent trading range of $7 per share. With a market cap of only $34 million and trailing 12-month revenues of more than $39 million, it won’t be long before Wall Street discovers this stock and it begins to get the respect it deserves.
You can learn more about AMEH by visiting the Company’s stock page where you’ll find our latest research report and interviews with management. Don’t miss your opportunity to accumulate shares at these low prices before the Company moves to NASDAQ and gets on the radar of institutional investors.
Disclosure: RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law, RedChip Companies, Inc., our specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information). Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov. Apollo Medical Holdings (AMEH) is a client of RedChip Companies, Inc. AMEH agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services, and 10,000 warrants with an exercise price of $9.00 and a three year term. Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.